[go: up one dir, main page]

AR109807A1 - Sistema de suministro transdérmico de pramipexol y usos del mismo - Google Patents

Sistema de suministro transdérmico de pramipexol y usos del mismo

Info

Publication number
AR109807A1
AR109807A1 ARP170102776A ARP170102776A AR109807A1 AR 109807 A1 AR109807 A1 AR 109807A1 AR P170102776 A ARP170102776 A AR P170102776A AR P170102776 A ARP170102776 A AR P170102776A AR 109807 A1 AR109807 A1 AR 109807A1
Authority
AR
Argentina
Prior art keywords
pramipexol
same
polymers
supply system
drug
Prior art date
Application number
ARP170102776A
Other languages
English (en)
Inventor
Taijung Wu
Catherine Lee
Original Assignee
Transwell Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transwell Biotech Co Ltd filed Critical Transwell Biotech Co Ltd
Publication of AR109807A1 publication Critical patent/AR109807A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Un parche transdérmico para tratar la enfermedad de Parkinson, que comprende: (i) una capa que contiene fármaco; (ii) una capa de refuerzo; y (iii) una capa protectora, en donde la capa que contiene fármaco comprende pramipexol o una sal farmacéuticamente aceptable del mismo y dos o más polímeros, en donde por lo menos dos de los polímeros comprenden cada uno un grupo funcional carboxilo y/o un grupo funcional hidroxilo. Reivindicación 4: El parche transdérmico de conformidad con la reivindicación 1, caracterizado además porque los por lo menos dos polímeros cada uno comprende un polímero a base de acrilato.
ARP170102776A 2016-10-07 2017-10-05 Sistema de suministro transdérmico de pramipexol y usos del mismo AR109807A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/055866 WO2018067163A1 (en) 2016-10-07 2016-10-07 Pramipexole transdermal delivery system and uses thereof

Publications (1)

Publication Number Publication Date
AR109807A1 true AR109807A1 (es) 2019-01-23

Family

ID=61830567

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170102776A AR109807A1 (es) 2016-10-07 2017-10-05 Sistema de suministro transdérmico de pramipexol y usos del mismo

Country Status (7)

Country Link
US (2) US10729679B2 (es)
EP (1) EP3522843B1 (es)
JP (1) JP6978417B2 (es)
KR (1) KR102699924B1 (es)
CN (3) CN114796163A (es)
AR (1) AR109807A1 (es)
WO (1) WO2018067163A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116650447B (zh) * 2023-04-24 2025-10-28 广州新济药业科技有限公司 凝胶贴膏剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US330922A (en) * 1885-11-24 Music-rack and walking-cane combined
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
DE10137082A1 (de) * 2001-07-28 2003-02-13 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
PE20040134A1 (es) * 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
DE10333393A1 (de) * 2003-07-23 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit dem Wirkstoff Pramipexol
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
RU2356580C2 (ru) * 2003-10-28 2009-05-27 Новен Фармасьютикалз, Инк Композиции и способы, обеспечивающие контролируемую потерю лекарственных средств и доставку в системах трансдермальной доставки лекарственных средств
US8343538B2 (en) * 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
CN101147739B (zh) 2007-07-06 2010-12-08 北京康倍得医药技术开发有限公司 含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
DE102012205493A1 (de) * 2012-04-03 2013-10-10 Acino Ag Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem
US9682068B2 (en) * 2013-05-20 2017-06-20 Mylan Inc. Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
CN103432104B (zh) * 2013-08-09 2015-10-28 大连理工大学 一种含有普拉克索的透皮贴剂
CN103610666A (zh) 2013-12-11 2014-03-05 中国药科大学 一种盐酸普拉克索透皮贴剂及其制备方法
EP3067050A1 (en) * 2015-03-13 2016-09-14 Acino AG Transdermal therapeutic system with an overtape comprising two adhesive layers

Also Published As

Publication number Publication date
CN114668747A (zh) 2022-06-28
CN109310526A (zh) 2019-02-05
CN114796163A (zh) 2022-07-29
EP3522843A4 (en) 2020-04-29
US20180098973A1 (en) 2018-04-12
CA3003460A1 (en) 2018-04-12
KR20190065184A (ko) 2019-06-11
US20200368209A1 (en) 2020-11-26
WO2018067163A1 (en) 2018-04-12
KR102699924B1 (ko) 2024-08-29
JP2019529332A (ja) 2019-10-17
US11291656B2 (en) 2022-04-05
EP3522843B1 (en) 2022-09-21
US10729679B2 (en) 2020-08-04
EP3522843A1 (en) 2019-08-14
JP6978417B2 (ja) 2021-12-08
CN109310526B (zh) 2022-05-17

Similar Documents

Publication Publication Date Title
MX2021004639A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos.
PE20160002A1 (es) Sistema de liberacion transdermico
MX2019001103A (es) Sistema de suministro transdermico de donepezilo.
CL2016002753A1 (es) Composición conservante de la madera
BR112014014137A2 (pt) sistema de liberação transdérmica compreendendo buprenorfina
BR112017023904A2 (pt) derivados indol mono- ou dissubstituídos como inibidores da replicação viral da dengue
BR112018077021A2 (pt) terapias de combinação
MX379297B (es) Compuestos alqueno tetrasustituidos y su uso.
BR112017006299A2 (pt) derivados indol mono- ou dissubstituídos como inibidores da replicação viral da dengue
BR112015001801A2 (pt) métodos e composições para determinar a resistência à terapia de receptor de androgênio
ECSP18073366A (es) Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue
MX2015012559A (es) Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson.
BR112017025108A2 (pt) compostos seletivos de pyy e usos dos mesmos
MX2019007389A (es) Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
BR112018068956A2 (pt) derivados do composto indol substituídos como inibidores da replicação viral da dengue
CO2018009563A2 (es) Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue
BR112015024271A2 (pt) sistema de fornecimento transdérmico
BR112019024322A2 (pt) Compostos e composições terapêuticos e métodos de uso dos mesmos
MX2020003665A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo.
MX2019015676A (es) Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento.
MX2017015292A (es) Composicion para tratar lesiones cerebrales.
MX2021004709A (es) Metodo y medicamento para tratar cancer insensible a inhibidor de se?alizacion de pd-1/pd-l1.
AR100369A1 (es) Composición de dosis fija de formoterol y budesonide
BR112017009668A2 (pt) métodos de tratamento da ckd utilizando predictores de retenção de fluidos
AR109807A1 (es) Sistema de suministro transdérmico de pramipexol y usos del mismo

Legal Events

Date Code Title Description
FB Suspension of granting procedure